Can VEGF-D and VEGFR-3 be used as biomarkers for therapeutic decisions in patients with gastric cancer? Commentary

Nature Clinical Practice Oncology

Volumn 3, Issue 8, 2006, Pages 418-419

  Roukos, Dimitrios H ^a   Liakakos, Theodore ^c   Karatzas, Gabriel ^c   Kappas, Angelos M ^b  

^a Genomics Research Unit

^b UNIVERSITY OF IOANNINA   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUMOR MARKER; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; SHORT SURVEY; STOMACH ADENOCARCINOMA; SURVIVAL RATE; SURVIVAL TIME;

EID: 33747026765     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0540     Document Type: Short Survey

References (5)

1. Roukos DH and Kappas AM (2005) Perspectives in the treatment of gastric cancer. Nat Clin Pract Oncol 2: 98-107
2. Simon R (2005) Roadmap for developing and validating therapeutically relevant genomic classifiers. J Clin Oncol 23: 7332-7341
3. Ransohoff DF (2005) Bias as a threat to the validity of cancer molecular-marker research. Nat Rev Cancer 5: 142-149
4. Kattan MW et al. (2005) Postoperative nomogram for disease-specific survival after an RO resection for gastric carcinoma. J Clin Oncol 21: 3647-3650
5. Chen CN et al. (2005) Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 23: 7286-7295